We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Cryoport Inc (CYRX) USD0.01

Sell:$20.09 Buy:$46.30 Change: $2.69 (6.83%)
Market closed |  Prices as at close on 8 August 2022 | Switch to live prices |
Change: $2.69 (6.83%)
Market closed |  Prices as at close on 8 August 2022 | Switch to live prices |
Change: $2.69 (6.83%)
Market closed |  Prices as at close on 8 August 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Cryoport, Inc. is a provider of integrated temperature-controlled supply-chain solutions to the biopharma/pharma, animal health, and reproductive medicine markets. The Company provides supply chain technologies and services through its brands, such as Cryoport Systems, CryoStork, MVE Biological Solutions, CRYOPDP, and CRYOGENE. The Company's products include Cryoport Express Shippers, Cryoport ELITE Shippers, Cryoport Cryosphere, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature Controlled Logistics, CRYOPDP Direct to Patient Solutions, CRYOPDP Control Tower Solution, MVE Biological Solutions Fusion Cryogenic Freezers and MVE Biological Solutions Vario Cryogenic Freezer. It operates primarily in Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC). Its subsidiaries include Cryoport Systems, LLC, Cryogene, Inc., MVE Biological Solutions, US LLC, Cryoport Netherlands B.V., and Cell&Co; BioServices.

Contact details

112 Westwood Place, Suite 350
United States
+1 (949) 2321900

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.95 billion
Shares in issue:
49.38 million
Health Care Equipment
United States
US dollar

Key personnel

  • Jerrell Shelton
    Chairman of the Board, President, Chief Executive Officer
  • Robert Stefanovich
    Chief Financial Officer, Senior Vice President, Chief Administrative Officer
  • Mark Sawicki
    Senior Vice President, Chief Scientific Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.